To the Editor With initial amazement we read the recent Viewpoint of Shankaran et al.1 The practice of “Big Pharma” to scam patients at one of the most vulnerable moments of their lives with excessive drug cost is far from dignified.
Over the years, the practice of euthanasia and/or physician-assisted death has been confronted with fierce opposition. But even the most creative critics using different formats of the “slippery slope” argument would never have come up with the intolerable practices of pharmaceutical firms.2,3
De Hert M, Distelmans W. The Bitter, Expensive Pill at the End of Life. JAMA Oncol. 2017;3(11):1587–1588. doi:10.1001/jamaoncol.2017.1650
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.